NO20084441L - Triazolonderivat - Google Patents

Triazolonderivat Download PDF

Info

Publication number
NO20084441L
NO20084441L NO20084441A NO20084441A NO20084441L NO 20084441 L NO20084441 L NO 20084441L NO 20084441 A NO20084441 A NO 20084441A NO 20084441 A NO20084441 A NO 20084441A NO 20084441 L NO20084441 L NO 20084441L
Authority
NO
Norway
Prior art keywords
optionally substituted
independently represent
represent hydrogen
represents optionally
independently
Prior art date
Application number
NO20084441A
Other languages
English (en)
Norwegian (no)
Inventor
Shinsuke Hirota
Kazutomi Kusano
Richard Clark
Fumiyoshi Matsuura
Kazunobu Kira
Hiroshi Azuma
Tadashi Nagakura
Tatsuo Horizoe
Kimiyo Tabata
Takao Omae
Atsushi Inoue
Original Assignee
Eisai R&D Man Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Man Co Ltd filed Critical Eisai R&D Man Co Ltd
Publication of NO20084441L publication Critical patent/NO20084441L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20084441A 2006-03-24 2008-10-22 Triazolonderivat NO20084441L (no)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP2006083486 2006-03-24
US78668706P 2006-03-29 2006-03-29
JP2006162594 2006-06-12
US80487806P 2006-06-15 2006-06-15
JP2006218819 2006-08-10
US83841806P 2006-08-18 2006-08-18
PCT/JP2007/055813 WO2007111212A1 (fr) 2006-03-24 2007-03-22 Dérivé de triazolone

Publications (1)

Publication Number Publication Date
NO20084441L true NO20084441L (no) 2008-12-22

Family

ID=38950011

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084441A NO20084441L (no) 2006-03-24 2008-10-22 Triazolonderivat

Country Status (25)

Country Link
US (3) US7816522B2 (fr)
EP (2) EP2194046B1 (fr)
JP (1) JP5016592B2 (fr)
KR (1) KR101362024B1 (fr)
AT (2) ATE557010T1 (fr)
AU (1) AU2007230346B2 (fr)
BR (1) BRPI0709101A2 (fr)
CA (1) CA2647423C (fr)
CY (1) CY1111271T1 (fr)
DE (1) DE602007011231D1 (fr)
DK (1) DK2000465T3 (fr)
HR (1) HRP20110054T1 (fr)
IL (1) IL194188A (fr)
MX (1) MX2008012031A (fr)
MY (1) MY146537A (fr)
NO (1) NO20084441L (fr)
NZ (1) NZ571441A (fr)
PL (1) PL2000465T3 (fr)
PT (1) PT2000465E (fr)
RS (1) RS52030B (fr)
SA (1) SA07280131B1 (fr)
SI (1) SI2000465T1 (fr)
TW (1) TWI389894B (fr)
WO (1) WO2007111212A1 (fr)
ZA (1) ZA200805758B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006041119A1 (fr) * 2004-10-13 2006-04-20 Eisai R & D Management Co., Ltd. Dérivés d’hydrazide
CA2647423C (fr) 2006-03-24 2015-02-17 Eisai R&D Management Co., Ltd. Derive de triazolone
WO2009038157A1 (fr) * 2007-09-21 2009-03-26 Eisai R & D Management Co., Ltd. Dérivé de 2,3-dihydroiminoisoindole
JP2011500798A (ja) * 2007-10-26 2011-01-06 アストラゼネカ・アクチエボラーグ ｍＧｌｕＲ５のモジュレーターとしてのアミノ１，２，４−トリアゾール誘導体
WO2009054791A1 (fr) * 2007-10-26 2009-04-30 Astrazeneca Ab Dérivés de 1,2,4-triazole pyrrolidine fusionnés utilisés en tant que modulateurs de mglur5
TW201206905A (en) 2010-05-20 2012-02-16 Eisai R & Amp D Man Co Ltd Prodrug of triazolone compound
EP2822931B1 (fr) 2012-03-09 2017-05-03 Inception 2, Inc. Composés de triazolone et leurs utilisations
CN102993109A (zh) * 2012-12-03 2013-03-27 浙江工业大学 一种脒化合物的制备方法
ES2660249T3 (es) 2012-12-20 2018-03-21 Inception 2, Inc. Compuestos de tipo triazolona y sus usos
JP2016529311A (ja) 2013-09-06 2016-09-23 インセプション ２、 インコーポレイテッド トリアゾロン化合物類及びそれらの使用
WO2018155260A1 (fr) * 2017-02-23 2018-08-30 株式会社Ihi Sonde de détection de radicaux oh, dispositif de mesure de radicaux oh et procédé de mesure de radicaux oh

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2005000A (en) * 1931-07-18 1935-06-18 L N Miller Engineering Corp Differential motor
EP0019586A1 (fr) 1979-05-11 1980-11-26 Ciba-Geigy Ag Mélanges antithrombotiques
SU1512055A1 (ru) 1987-12-04 1992-07-23 Пермский фармацевтический институт Дигидрохлорид гидразида N-ацетил-N-аллилантраниловой кислоты, про вл ющий антиагрегатную активность по отношению к тромбоцитам плазмы крови
EP1020434A4 (fr) 1997-08-27 2000-11-15 Kissei Pharmaceutical Derives de 3-amidinoaniline, inhibiteurs du facteur x de coagulation sanguine activee, et intermediaires de production de ces derives et de ces inhibiteurs
US6358960B1 (en) 1998-02-17 2002-03-19 Ono Pharmaceutical Co., Ltd. Amidino derivatives and drugs containing the same as the active ingredient
AU3110999A (en) * 1998-03-27 1999-10-18 Du Pont Pharmaceuticals Company Disubstituted pyrazolines and triazolines as factor xa inhibitors
HK1043106A1 (zh) 1998-12-14 2002-09-06 F. Hoffmann-La Roche Ag 苯基甘氨酸衍生物
CN100488947C (zh) 1999-01-13 2009-05-20 杰南技术公司 丝氨酸蛋白酶抑制剂
FR2791683A1 (fr) 1999-03-30 2000-10-06 Synthelabo Derives de n-sulfonyl-dipeptides, leur preparation et leur application en therapeutique
FR2793247B1 (fr) 1999-05-04 2001-06-22 Synthelabo Derives de 6-[[(aryl et heteroaryl)oxy]methyl]naphtalene-2- carboximidamide, leur preparation et leur application en therapeutique
US6548694B2 (en) 2000-05-23 2003-04-15 Hoffman-La Roche Inc. N-(4-carbamimidoyl-phenyl)-glycine derivatives
EP1162194A1 (fr) 2000-06-06 2001-12-12 Aventis Pharma Deutschland GmbH Dérivés de (thio)-urée inhibiteurs du facteur VIIa, procédé de leur préparation et leur utilisation
US7476688B2 (en) 2001-04-19 2009-01-13 Eisai R&D Management Co., Ltd. Cyclic amidine derivatives
JP4209659B2 (ja) * 2001-11-15 2009-01-14 エーザイ・アール・アンド・ディー・マネジメント株式会社 アミジノ誘導体並びにそれを用いた抗血液凝固剤および血栓症治療剤
EP1312602A1 (fr) 2001-11-15 2003-05-21 Eisai Co., Ltd. Dérivés amidino et leur utilisation comme agents anticoagulantes et antithrombotiques
AU2003284001A1 (en) * 2002-10-07 2004-05-04 Bristol-Myers Squibb Company Triazolone and triazolethione derivatives
EP1479679A1 (fr) * 2003-05-19 2004-11-24 Aventis Pharma Deutschland GmbH Dérivés de triazoles en tant qu'inhibiteurs du facteur Xa
WO2006041119A1 (fr) 2004-10-13 2006-04-20 Eisai R & D Management Co., Ltd. Dérivés d’hydrazide
ATE405553T1 (de) 2004-12-08 2008-09-15 Bristol Myers Squibb Co Heterocyclische verbindungen als inhibitoren von faktor viia
CA2647423C (fr) 2006-03-24 2015-02-17 Eisai R&D Management Co., Ltd. Derive de triazolone
WO2009038157A1 (fr) 2007-09-21 2009-03-26 Eisai R & D Management Co., Ltd. Dérivé de 2,3-dihydroiminoisoindole

Also Published As

Publication number Publication date
BRPI0709101A2 (pt) 2011-06-28
US7816522B2 (en) 2010-10-19
KR20090014341A (ko) 2009-02-10
CA2647423A1 (fr) 2007-10-04
JP5016592B2 (ja) 2012-09-05
IL194188A (en) 2013-08-29
CA2647423C (fr) 2015-02-17
DE602007011231D1 (de) 2011-01-27
US20080015199A1 (en) 2008-01-17
AU2007230346B2 (en) 2011-12-22
EP2000465A1 (fr) 2008-12-10
AU2007230346A1 (en) 2007-10-04
EP2194046A1 (fr) 2010-06-09
SA07280131B1 (ar) 2010-03-08
US20110112109A1 (en) 2011-05-12
US8163787B2 (en) 2012-04-24
EP2000465B1 (fr) 2010-12-15
WO2007111212A1 (fr) 2007-10-04
TWI389894B (zh) 2013-03-21
JPWO2007111212A1 (ja) 2009-08-13
PL2000465T3 (pl) 2011-05-31
HK1123808A1 (en) 2009-06-26
US7928228B2 (en) 2011-04-19
KR101362024B1 (ko) 2014-02-11
ATE491694T1 (de) 2011-01-15
EP2000465A4 (fr) 2009-08-26
NZ571441A (en) 2010-08-27
ZA200805758B (en) 2009-12-30
EP2194046B1 (fr) 2012-05-09
SI2000465T1 (sl) 2011-04-29
MX2008012031A (es) 2008-10-02
DK2000465T3 (da) 2011-02-07
ATE557010T1 (de) 2012-05-15
RS52030B (sr) 2012-04-30
TW200745063A (en) 2007-12-16
US20100190783A1 (en) 2010-07-29
PT2000465E (pt) 2011-02-10
MY146537A (en) 2012-08-15
CY1111271T1 (el) 2015-08-05
HRP20110054T1 (hr) 2011-02-28

Similar Documents

Publication Publication Date Title
CY1111271T1 (el) Παραγωγο τριαζολονης
EP1953154A4 (fr) Composes cinnamide de type morpholine
NO20062370L (no) Amidderivater
NO20053748L (no) Pyrrolopyridazinderivater.
AR062100A1 (es) Compuestos y composiciones como moduladores de la senda de hedgehog
PT2415771E (pt) Derivado de indolizina e sua utilização para fins médicos
NO20064599L (no) Substituerte morfolin- og tiomorfolinderivater
NO20050134L (no) Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse
WO2004096761A8 (fr) Derives d'oxyphenyl aromatique et de sylfanylphenyl aromatique
EP2266969A3 (fr) Dérivés de 6-(pyridinyl)-4-pyrimidone en tant qu'inhibiteurs de la protéine kinase tau 1
NO20071008L (no) Fremgangsmate for fremstilling av N-piperidino-1,5-difenylpyrazol-3-karboksamidderivater
NO20076000L (no) Aminosyrederivater
NO20051011L (no) Kirale oksazol-arylpropionsyrederivater og anvendelse derav som PPAR agonister
WO2009038157A1 (fr) Dérivé de 2,3-dihydroiminoisoindole
DE60002558D1 (de) Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B
UA90483C2 (uk) Похідні n-(1н-індоліл)-1н-індол-2-карбоксамідів, їх отримання і їх застосування в терапії
IL166103A0 (en) Pyrrolidine derivatives and their use
NO20060718L (no) Substituerte tiofoner og deres anvendelse
IL187917A (en) Compounds 1– (Converted phenyl) -pyreno [3,4– b] [1] benzofuran-3-van
EP2045258A4 (fr) Dérivé de 3'-éthynylcytidine
NO20076089L (no) Fremgangsmate for fremstilling av 3,7-dihydroksy-1,5-diazacyklooktaner
WO2007054484A8 (fr) Procédé de fabrication de dérivés benzoxazinoniques bétamimétiques
ATE289812T1 (de) Azolylcarbynol-derivative von aryl (oder heteroaryl) zur behandlung von atemwegserkrankungen
EA200600542A1 (ru) Способ для производства thip
MA27745A1 (fr) Derives d'acide benzoylureidopyridyl-piperidine et pyrrolidinecarboxylique substitues, methode de production de ceux-ci et utilisation de ceux-ci.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application